ARQT PDUFA
PR to PDUFA Information: https://investors.arcutis.com/news-releases/news-release-details/fda-accepts-arcutis-biotherapeutics-new-drug-application
PR to PDUFA Information: https://investors.arcutis.com/news-releases/news-release-details/fda-accepts-arcutis-biotherapeutics-new-drug-application
BLCT has this special shareholder meeting scheduled to approve (or not) a merger. The valuation of a company can shift wildly during the runup and the period after the event, in these cases. A trader would want to have the technicals set up on their Think or Swim and keep an eye on the 1 […]